2019 Annual Meeting
Registration for the 2019 Annual NEALS Meeting is now OPEN! The 18th Annual NEALS Meeting will be held October 2nd - 4th, 2019 at the Opal Sands Resort in Clearwater Beach, Florida.
The Annual NEALS Meeting will host over 400 NEALS members, foundation partners, company representatives and ALS researchers. The 2019 NEALS Meeting will feature research updates, member presentations, an abstract poster session, a Science Symposium focused on TDP-43, and numerous networking opportunities. The meeting will also feature various training sessions for NEALS members. For more information on the member training sessions, click here.
2019 Abstract Guidelines
Thank you to everyone who submitted an abstract! We received a record number of abstract submissions for the 2019 Annual NEALS Meeting with a total of 122 submissions!
All poster presentation guidelines can be found here.
If you wish to ship your poster or other materials to the meeting location, please use the following address:
Opal Sands Resort
Annual NEALS Meeting
c/o Lynne Grant, Associate Director of Conference Services
Hold for: _____your name here__________
430 S Gulfview Blvd
Clearwater Beach, Florida 33767
NEALS Member/Industry Roundtable
Each year the NEALS Annual Meeting brings together the NEALS membership with foundation and industry partners. Join us in an open discussion on the evolving landscape of ALS trials with the NEALS membership and a panel of Industry partners on Wednesday, October 2nd from 4pm – 6pm. We are interested in continued dialogue with our foundation and industry partners in order to discuss the gaps and opportunities facing the field and how these might best be addressed and leveraged. This year's industry roundtable discussion is designed to raise important and timely issues around ALS clinical trials in order to generate discussion among clinical trialists, the companies interested in running clinical trials, and the foundations interested in supporting these efforts.
The topics we plan to discuss during the roundtable will include:
- Innovative clinical trial designs in ALS
- Application of technology to ALS clinical trials
- Potential surrogate markers for accelerated approval / functional endpoints as approval endpoints
- Thoughts about EAP and OLE in drug development
We hope to see you there!